---
figid: PMC9315613__pharmaceuticals-15-00808-g002
pmcid: PMC9315613
image_filename: pharmaceuticals-15-00808-g002.jpg
figure_link: /pmc/articles/PMC9315613/figure/pharmaceuticals-15-00808-f002/
number: Figure 2
figure_title: ''
caption: 'Simplified scheme of the energetic metabolism in cancer cells. Aerobic Glycolysis,
  Pentose Pyruvate Pathway, and TCA cycle. Natural compounds which inhibit the glycolytic
  pathway according to in vitro studies (the ligand-binding screening studies without
  in vitro testing were excluded): 1. Apigenin, 2. Berberine, 3. Bergapten, 4. Chrysin,
  5. Costunolide, 6. Daidzein, 7. Deguelin, 8. Dioscin, 9. Epigallocatechin, 10. Epigallocatechin
  gallate, 11. Galloflavin, 12. Genistein, 13. Gliotoxin, 14. Glucopiericidin A, 15.
  Kaempferol, 16. Oleanolic acid, 17. Oroxylin A, 18. Phloretin, 19. Pseurotin A,
  20. Prosapogenin A, 21. Quercetin, 22. Resveratrol, 23. Scutellarin, 24. Silybin,
  25. Shikonin, 26. Sulforaphane, 27. Wogonin, 28. Worenine, 29. Xanthohumol. The
  red-colored enzymes represent key regulators of the glycolytic pathway.'
article_title: 'Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling
  Pathways: Evidence from In Vitro Studies.'
citation: Ioana-Ecaterina Pralea, et al. Pharmaceuticals (Basel). 2022 Jul;15(7):808.
year: '2022'

doi: 10.3390/ph15070808
journal_title: Pharmaceuticals
journal_nlm_ta: Pharmaceuticals (Basel)
publisher_name: MDPI

keywords:
- phytochemicals
- tumor glycolysis
- tumor hypoxia
- Warburg effect
- HIF-1 signaling pathway
- metabolomics

---
